Omm Scientific, Inc

Company Information
Address 2600 N Stemmons Freeway, Suite 129
Dallas, TX, -

http://www.ommscientific.com

Information

DUNS: 610369535

# of Employees: 6


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Selective Oxidation of Heterocyclic Amines

    Amount: $499,916.00

    Two small businesses have teamed towards a Phase II Enhancement based on their unique qualifications to meet the requirements of the Army. Omm Scientific, Inc. is currently working with their Air Forc ...

    SBIRPhase II2016Department of Defense Army
  2. Development of a Broad Spectrum Antiviral for Ebola and Marburg viral Infections

    Amount: $438,476.00

    DESCRIPTION provided by applicant The long term goal of this project is to gain FDA approval for commercialization of a broad spectrum small molecule antiviral agent that is effective in treating ...

    STTRPhase I2015Department of Health and Human Services
  3. Rapid Feasibility Studies for Novel Routes to Direct CL-20 Intermediates

    Amount: $79,996.00

    The overall technical objective is to identify one or more promising synthetic methods for the preparation of a direct intermediate to CL-20 that uses commodity reagents and enable CL-20 to be prepare ...

    SBIRPhase I2014Navy Department of Defense
  4. Selective Oxidation of Heterocyclic Amines

    Amount: $749,999.00

    ABSTRACT: This proposal sets out a plan to continue the method development for selective chemical oxidization of one amine of a polyamino, multi-heterocyclic class of energetic materials. The approa ...

    STTRPhase II2013Department of Defense Air Force
  5. TOPIC 323 PHASE I; DEVELOPMENT OF RADIATION MODULATORS FOR USE DURING RADIOTHERAP

    Amount: $249,997.00

    Radiation insensitive tumors that become radiation resistant are often also invasive, metastatic, and responsible for most cancer deaths. Here, the long term objective is to complete clinical evaluati ...

    SBIRPhase I2013Department of Health and Human Services
  6. SBIR TOPIC 255, PHASE I: DEVELOPMENT OF ANTICANCER VATPASE INHIBITORS

    Amount: $199,931.00

    Invasive, metastatic, and/or drug resistant cancers are responsible for most cancer deaths. Development of a drug that blocks these phenotypes to improve outcomes is the ultimate objective. The speci ...

    SBIRPhase I2011Department of Health and Human Services
  7. Selective Oxidation of Heterocyclic Amines

    Amount: $100,000.00

    ABSTRACT: New energetic materials are needed for use in explosives and propellants that have a very powerful energy release yet are insensitive to handling. Safer materials that also allow developme ...

    STTRPhase I2011Air Force Department of Defense
  8. Ratiometric SPCE Detection of miRNA

    Amount: $167,231.00

    DESCRIPTION (provided by applicant): Fluorescence technologies are key research tools in the life sciences, biotechnology, medical diagnostics, forensics, and other fields. Fluorescence-based measurem ...

    STTRPhase I2009Department of Health and Human Services
  9. Improved Methodology for RNA Synthesis

    Amount: $99,014.00

    DESCRIPTION (provided by applicant): The overall objective of this application is to show that 2'O-(N,N-dimethylthiocarbamate) (DMTC) protected monomers (see Fig. 1) can be used as effectively in the ...

    SBIRPhase I2007Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government